{"id":3850,"date":"2025-04-09T11:06:52","date_gmt":"2025-04-09T10:06:52","guid":{"rendered":"https:\/\/oximio.com\/?post_type=oximio-resources&p=3850"},"modified":"2025-04-09T11:24:49","modified_gmt":"2025-04-09T10:24:49","slug":"us-withdrawal-from-who-africa-implications","status":"publish","type":"oximio-resources","link":"https:\/\/oximio.com\/resources\/us-withdrawal-from-who-africa-implications\/","title":{"rendered":"US WHO & USAID Policy Changes: Impact on Africa’s Healthcare"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\"US<\/p>

The US policy changes to withdraw from the World Health Organization and cut United States Agency for International Development (USAID) have had repercussions on clinical trials and humanitarian programmes across Africa. We explore the impact on clinical supply teams on the ground who are dealing with the consequences.<\/p>

The clinical supply chain in Africa is striving to manage the impact of the US decision to withdraw from the World Health Organization (WHO) and significantly reduce USAID.<\/p>

The US administration has indicated it will formally exit the WHO in January 2026. Given the annual US WHO contributions amounted to a reported $1bn in recent years, the nation\u2019s withdrawal will put a sizeable dent in the organisation\u2019s budget.<\/p>

Further challenging news for the clinical supply chain came when the US administration announced plans to reduce USAID contracts. In March 2025, it was confirmed that 83% of USAID programmes would\u00a0end<\/a>. Some reports suggest that as much as\u00a0$60bn in funding<\/a>\u00a0could be pulled globally as a result.<\/p>

These decisions certainly create challenges in Africa.\u00a0The region has the highest disease burden of any continent. Aid programmes provide a literal lifeline for countless people. Crucially, Africa has so much to offer in clinical trials, with a diverse and unsaturated patient pool that is largely untapped for the development of new drugs. There is much to offer for parties stepping in to fill some of the gaps.<\/p>

How US cuts are predicted to drive an increase in infection rates<\/h2>

The US policy changes have raised concerns about increases in mortality rates. Experts have predicted that the changes could lead to new strains of\u00a0tuberculous that lack treatments<\/a>.<\/p>

Even before the recent US announcements, Mycobacterium\u00a0tuberculosis infections were forecast to rise in South Africa between 2024 and 2033, according to epidemiologists from GlobalData. In 2024, there were 370,000 diagnosed cases. By 2033, this is projected to rise to more than 430,000 diagnoses. These figures gave South Africa the highest number of M tuberculosis cases across the 16 major pharma markets in 2024, with more than 615 infections per 100,000 people.<\/p>

In addition, there were warnings that the roll-back of US support could result in\u00a0a spike in malaria cases<\/a>\u00a0across Africa as the number of vaccines available reduces.<\/p>

There are also predictions that the US policy changes could lead to the deaths of\u00a0500,000 people from HIV\/AIDS just in South Africa<\/a>\u00a0within the next decade.<\/p>

\u201cLook at South Africa as just one example. As of 2025, the estimated HIV prevalence rate in South Africa is approximately 12.7% of the population. This translates to around eight million people living with HIV,\u201d explains Celeste de Vries, Regional Director of sub-Saharan Africa for Oximio.<\/p>

Oximio is a specialist provider of clinical logistics solutions in several locations worldwide and works throughout sub-Saharan Africa. In South Africa, Oximio has a specialist facility that offers temperature control storage for medical supplies, with a customs-bonded warehouse in Kenya.<\/p>

The impact of US policy changes on the clinical supply chain<\/h2>

Sources on the ground suggest that clinical trials in Africa are already being cancelled and companies are pulling products from storage facilities.<\/p>

The US policy changes have also caused knock-on effects that must be assessed to fully understand the scale of the challenges now facing wider healthcare in Africa.<\/p>

\u201cThe impact of medication and financial support for HIV alone is far-reaching,\u201d adds de Vries on the situation.\u00a0<\/p>

It is not just patients who are affected, but also the increased burden on the medical care facilities and staff, the home support structures, as well as the possibility that the sick and vulnerable may lose their income or spend more money on accessing treatments.<\/p>

Adapting to global instability in the clinical supply chain<\/h2>

The US policy changes are being felt throughout the supply chain, back to the manufacturers. \u201cThe impact is real and it\u2019s not just on the patient,\u201d says de Vries. \u201cFrom a business point of view, the impact is immediate.\u201d<\/p>

The ability to adapt is vital for businesses working in the clinical supply chain. To help to mitigate these new challenges, partnerships are vital. Other countries, private sector initiatives, and local governments are stepping in to manage the consequences.<\/p>

Oximio is also working closely with its clients and partners wherever possible to develop solutions. While there is a limit to how much help the company can provide, options are being explored.\u00a0<\/p>

\u201cWe\u2019ve made a commitment to our clients to sit with them individually and hear all their concerns and address them one-by-one,\u201d adds de Vries. \u201cWe can\u2019t, from an ethical perspective, say we\u2019re going to stop managing your trials, medication, or products. We can\u2019t not charge any fees. But we can come up with solutions for each client.\u201d<\/p>

Africa has much to offer clinical trials. For a continent with so much untapped potential, those willing to provide support can still reap the many rewards in these challenging circumstances. Despite the downward health predictions, there remains resilience and a hint of optimism in the clinical supply chain.<\/p>

And with challenges will come eventual solutions. \u201cThere is a spark of hope,\u201d adds de Vries.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"featured_media":3853,"template":"","meta":{"_acf_changed":false},"resources-categories":[6],"class_list":["post-3850","oximio-resources","type-oximio-resources","status-publish","has-post-thumbnail","hentry","resources-categories-insights"],"acf":[],"yoast_head":"\nUS WHO & USAID Policy Changes: Impact on Africa's Healthcare<\/title>\n<meta name=\"description\" content=\"Insight into Clinical Consequences of US Withdrawal from WHO and USAID on Africa's Healthcare from Oximio, Clinical Trial Logistics Provider\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/oximio.com\/tr\/resources\/us-withdrawal-from-who-africa-implications\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"US WHO & USAID Policy Changes: Impact on Africa's Healthcare\" \/>\n<meta property=\"og:description\" content=\"Insight into Clinical Consequences of US Withdrawal from WHO and USAID on Africa's Healthcare from Oximio, Clinical Trial Logistics Provider\" \/>\n<meta property=\"og:url\" content=\"https:\/\/oximio.com\/resources\/us-withdrawal-from-who-africa-implications\/\" \/>\n<meta property=\"og:site_name\" content=\"Oximio\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Oximio\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-09T10:24:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/oximio.com\/wp-content\/uploads\/2025\/04\/US-flag.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"1385\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/oximio.com\/resources\/us-withdrawal-from-who-africa-implications\/\",\"url\":\"https:\/\/oximio.com\/resources\/us-withdrawal-from-who-africa-implications\/\",\"name\":\"US WHO & USAID Policy Changes: Impact on Africa's Healthcare\",\"isPartOf\":{\"@id\":\"https:\/\/oximio.com\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/oximio.com\/resources\/us-withdrawal-from-who-africa-implications\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/oximio.com\/resources\/us-withdrawal-from-who-africa-implications\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/oximio.com\/wp-content\/uploads\/2025\/04\/US-flag.jpg\",\"datePublished\":\"2025-04-09T10:06:52+00:00\",\"dateModified\":\"2025-04-09T10:24:49+00:00\",\"description\":\"Insight into Clinical Consequences of US Withdrawal from WHO and USAID on Africa's Healthcare from Oximio, Clinical Trial Logistics Provider\",\"breadcrumb\":{\"@id\":\"https:\/\/oximio.com\/resources\/us-withdrawal-from-who-africa-implications\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/oximio.com\/resources\/us-withdrawal-from-who-africa-implications\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/oximio.com\/resources\/us-withdrawal-from-who-africa-implications\/#primaryimage\",\"url\":\"https:\/\/oximio.com\/wp-content\/uploads\/2025\/04\/US-flag.jpg\",\"contentUrl\":\"https:\/\/oximio.com\/wp-content\/uploads\/2025\/04\/US-flag.jpg\",\"width\":1280,\"height\":1385,\"caption\":\"US Flag: What does the US withdrawal from the WHO and US Aid reduction mean for Africa?\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/oximio.com\/resources\/us-withdrawal-from-who-africa-implications\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/oximio.com\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"US WHO & USAID Policy Changes: Impact on Africa’s Healthcare\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/oximio.com\/tr\/#website\",\"url\":\"https:\/\/oximio.com\/tr\/\",\"name\":\"Oximio\",\"description\":\"We deliver care\",\"publisher\":{\"@id\":\"https:\/\/oximio.com\/tr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/oximio.com\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/oximio.com\/tr\/#organization\",\"name\":\"Oximio\",\"url\":\"https:\/\/oximio.com\/tr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/oximio.com\/tr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/oximio.com\/wp-content\/uploads\/2024\/09\/Oximio_logo-01.jpg\",\"contentUrl\":\"https:\/\/oximio.com\/wp-content\/uploads\/2024\/09\/Oximio_logo-01.jpg\",\"width\":2501,\"height\":1363,\"caption\":\"Oximio\"},\"image\":{\"@id\":\"https:\/\/oximio.com\/tr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Oximio\/\",\"https:\/\/www.linkedin.com\/company\/smo-group\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"US WHO & USAID Policy Changes: Impact on Africa's Healthcare","description":"Insight into Clinical Consequences of US Withdrawal from WHO and USAID on Africa's Healthcare from Oximio, Clinical Trial Logistics Provider","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/oximio.com\/tr\/resources\/us-withdrawal-from-who-africa-implications\/","og_locale":"tr_TR","og_type":"article","og_title":"US WHO & USAID Policy Changes: Impact on Africa's Healthcare","og_description":"Insight into Clinical Consequences of US Withdrawal from WHO and USAID on Africa's Healthcare from Oximio, Clinical Trial Logistics Provider","og_url":"https:\/\/oximio.com\/resources\/us-withdrawal-from-who-africa-implications\/","og_site_name":"Oximio","article_publisher":"https:\/\/www.facebook.com\/Oximio\/","article_modified_time":"2025-04-09T10:24:49+00:00","og_image":[{"width":1280,"height":1385,"url":"https:\/\/oximio.com\/wp-content\/uploads\/2025\/04\/US-flag.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/oximio.com\/resources\/us-withdrawal-from-who-africa-implications\/","url":"https:\/\/oximio.com\/resources\/us-withdrawal-from-who-africa-implications\/","name":"US WHO & USAID Policy Changes: Impact on Africa's Healthcare","isPartOf":{"@id":"https:\/\/oximio.com\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/oximio.com\/resources\/us-withdrawal-from-who-africa-implications\/#primaryimage"},"image":{"@id":"https:\/\/oximio.com\/resources\/us-withdrawal-from-who-africa-implications\/#primaryimage"},"thumbnailUrl":"https:\/\/oximio.com\/wp-content\/uploads\/2025\/04\/US-flag.jpg","datePublished":"2025-04-09T10:06:52+00:00","dateModified":"2025-04-09T10:24:49+00:00","description":"Insight into Clinical Consequences of US Withdrawal from WHO and USAID on Africa's Healthcare from Oximio, Clinical Trial Logistics Provider","breadcrumb":{"@id":"https:\/\/oximio.com\/resources\/us-withdrawal-from-who-africa-implications\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/oximio.com\/resources\/us-withdrawal-from-who-africa-implications\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/oximio.com\/resources\/us-withdrawal-from-who-africa-implications\/#primaryimage","url":"https:\/\/oximio.com\/wp-content\/uploads\/2025\/04\/US-flag.jpg","contentUrl":"https:\/\/oximio.com\/wp-content\/uploads\/2025\/04\/US-flag.jpg","width":1280,"height":1385,"caption":"US Flag: What does the US withdrawal from the WHO and US Aid reduction mean for Africa?"},{"@type":"BreadcrumbList","@id":"https:\/\/oximio.com\/resources\/us-withdrawal-from-who-africa-implications\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/oximio.com\/tr\/"},{"@type":"ListItem","position":2,"name":"US WHO & USAID Policy Changes: Impact on Africa’s Healthcare"}]},{"@type":"WebSite","@id":"https:\/\/oximio.com\/tr\/#website","url":"https:\/\/oximio.com\/tr\/","name":"Oximio","description":"We deliver care","publisher":{"@id":"https:\/\/oximio.com\/tr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/oximio.com\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Organization","@id":"https:\/\/oximio.com\/tr\/#organization","name":"Oximio","url":"https:\/\/oximio.com\/tr\/","logo":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/oximio.com\/tr\/#\/schema\/logo\/image\/","url":"https:\/\/oximio.com\/wp-content\/uploads\/2024\/09\/Oximio_logo-01.jpg","contentUrl":"https:\/\/oximio.com\/wp-content\/uploads\/2024\/09\/Oximio_logo-01.jpg","width":2501,"height":1363,"caption":"Oximio"},"image":{"@id":"https:\/\/oximio.com\/tr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Oximio\/","https:\/\/www.linkedin.com\/company\/smo-group"]}]}},"_links":{"self":[{"href":"https:\/\/oximio.com\/tr\/wp-json\/wp\/v2\/oximio-resources\/3850","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oximio.com\/tr\/wp-json\/wp\/v2\/oximio-resources"}],"about":[{"href":"https:\/\/oximio.com\/tr\/wp-json\/wp\/v2\/types\/oximio-resources"}],"version-history":[{"count":9,"href":"https:\/\/oximio.com\/tr\/wp-json\/wp\/v2\/oximio-resources\/3850\/revisions"}],"predecessor-version":[{"id":3860,"href":"https:\/\/oximio.com\/tr\/wp-json\/wp\/v2\/oximio-resources\/3850\/revisions\/3860"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oximio.com\/tr\/wp-json\/wp\/v2\/media\/3853"}],"wp:attachment":[{"href":"https:\/\/oximio.com\/tr\/wp-json\/wp\/v2\/media?parent=3850"}],"wp:term":[{"taxonomy":"resources-categories","embeddable":true,"href":"https:\/\/oximio.com\/tr\/wp-json\/wp\/v2\/resources-categories?post=3850"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}